Coronavirus (SARS-CoV-2): a systematic review for potential vaccines

Area of Science:

• Vaccinology
• Infectious Diseases
• Public Health

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, necessitates urgent development of effective and safe vaccines.
• Assessing existing and novel vaccine candidates is crucial for controlling the current and future outbreaks.

Purpose of the Study:

• To systematically review the availability, development status, and potential of new COVID-19 vaccine candidates.
• To evaluate vaccines for other diseases that may offer protection against SARS-CoV-2 infection.

Main Methods:

• Comprehensive literature search across major scientific databases (PubMed, MEDLINE, EMBASE, etc.) and clinical trial registries.
• Inclusion of published articles and ongoing clinical trial data to assess vaccine development progress.
• Systematic analysis of vaccine availability and developmental strategies.

Main Results:

• Pharmaceutical companies and research institutions are actively developing diverse COVID-19 vaccine candidates.
• Various stages of vaccine development are represented, from early research to advanced clinical trials.
• The potential efficacy of existing vaccines for other diseases against SARS-CoV-2 is under investigation.

Conclusions:

• Multiple vaccine candidates for COVID-19 are in development, requiring further rigorous evaluation.
• Continued research and extensive clinical trials are necessary to ensure vaccine safety and efficacy.
• A multifaceted approach, including exploring cross-protective vaccines, is vital for pandemic preparedness.